Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Virology|September 23, 2016
A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B ProteinFang Guo, Shuo Wu, Justin Julander, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2013
Design and synthesis of N-alkyldeoxynojirimycin derivatives with improved metabolic stability as inhibitors of BVDV and Tacaribe virusYanming Du, Hong Ye, Fang Guo, et al.
Antiviral Research|October 7, 2017
A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonistsBowei Liu, Liudi Tang, Xiaohui Zhang, et al.
Plos Pathogens|September 26, 2017
HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathwaysFang Guo, Qiong Zhao, Muhammad Sheraz, et al.
Plos Pathogens|January 21, 2022
A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune responseZhao Gao, Xuexiang Zhang, Lin Zhang, et al.
Antiviral Research|May 2, 2021
Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulatorsYue Luo, Junjun Cheng, Zhanying Hu, et al.
Journal of Virology|June 2, 2017
Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid AssemblyShuo Wu, Qiong Zhao, Pinghu Zhang, et al.
Journal of Medicinal Chemistry|June 21, 2012
Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infectionWenquan Yu, Tina Gill, Lijuan Wang, et al.
Antiviral Research|June 17, 2026
BDAA, a yellow fever virus NS4B inhibitor, is effective during therapeutic treatment in a hamster model of yellow feverAbbie E Weight, Arnaud J Van Wettere, Shawn M Zimmerman, et al.
Communications Biology|May 29, 2020
Quassinoid analogs with enhanced efficacy for treatment of hematologic malignancies target the PI3Kγ isoformYonggang Pei, Nicky Hwang, Fengchao Lang, et al.
Pageof 5